OR WAIT null SECS
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, announces the formation of a wholly owned subsidiary, TSO3 Corporation, structured under the laws of the state of Delaware, and located in South Carolina. The new entity is being created to meet the demands of U.S. customers for product, service and education.
"During the second quarter the company focused a great deal of its energies in developing a formal commercialization process for the STERIZONE® Sterilization System." says R.M. Rumble, president and CEO. "Alone and together with our sales and service partner Getinge Infection Control, the company has made great strides, which we believe will result in securing contract positions with the largest and leading GPOs and integrated delivery networks. In addition, TSO3 is ushering scores of quotes through their individual processes, many of which the company expects to successfully close. As a result of these efforts, it became clear that it was time to execute our plans to open a U.S. location focused on the education and ongoing service requirements of the U.S. customers."
Rumble adds, "While the foundation and technical expertise of the company is and will remain in Quebec City, establishing a presence in the U.S., which represents 40 percent of the worldwide market, will allow us to more effectively reach out to and service this high-opportunity market."
The company has leased approximately 6,000 square feet of space in Myrtle Beach, S.C. The location will house U.S. customer service, clinical education and also will act as a U.S. warehouse and service depot. The new location is expected to open in August.
The STERIZONE® VP4 Sterilizer developed by TSO3 is a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide (H2O2) and ozone. Its single cycle can sterilize a large number and wide range of compatible devices, thereby allowing for a cost effective and error-free sterilization process. TSO3's Dynamic Sterilant Delivery System automatically adjusts the quantity of injected sterilant based on the load composition, weight and temperature. With its large 75-pound load capacity and a short cycle time, the STERIZONE® VP4 Sterilizer can enhance throughput and lower sterilization cost. The STERIZONE® VP4 Sterilizer was cleared for commercialization in the U.S. in December 2014.
Source: TSO3, Inc.